(19)
(11) EP 3 183 347 A2

(12)

(88) Date of publication A3:
21.04.2016

(43) Date of publication:
28.06.2017 Bulletin 2017/26

(21) Application number: 15833669.3

(22) Date of filing: 17.10.2015
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
A61K 31/7105(2006.01)
A61P 25/08(2006.01)
C12N 15/85(2006.01)
A61K 48/00(2006.01)
(86) International application number:
PCT/IB2015/001917
(87) International publication number:
WO 2016/027168 (25.02.2016 Gazette 2016/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 20.08.2014 US 201462039819 P

(71) Applicant: Lifesplice Pharma LLC
Malvern, PA 19355 (US)

(72) Inventors:
  • TALLENT, Melanie
    Malvern, PA 19355 (US)
  • LYKENS, Nicole
    Malvern, PA 19355 (US)
  • LUTZ, Gordon
    Malvern, PA 19355 (US)

(74) Representative: Roques, Sarah Elizabeth 
J A Kemp 14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) SPLICE MODULATING OLIGONUCLEOTIDES AND METHODS OF USE THEREOF